Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 549957Generated: October 25, 2026

2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid → 2-[4-Chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]piperidin-1-yl}propan-1-one

https://huagongshe.com/reaction/549957

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acidHCID 17024557—
Reactant4-[4-(2-Phenylethyl)-1,3-thiazol-2-yl]piperidine hydrochlorideHCID 67156883—
Product2-[4-Chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]piperidin-1-yl}propan-1-oneHCID 67156500—

Reaction Steps

4-[4-(2-Phenylethyl)-1,3-thiazol-2-yl]piperidine hydrochloride (II-1, 309 mg) is reacted analogously to Example I-63 with 2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid (282 mg). After chromatographic purification, this gives 2-[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(2-phenylethyl)-1,3-thiazol-2-yl]piperidin-1-yl}propan-1-one (165 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07943774B2
Source datasetuspto-grants-2011_05
ORD IDord-a487b60aeb264923ab8893024ca8c473
Source noteuspto-grants-2011_05